Developing assays for kinase drug discovery – where have the advances come from?

Author： Vogel Kurt W   Zhong Zhong   Bi Kun   Pollok Brian A  

Publisher： Informa Healthcare

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.3, Iss.1, 2008-01, pp. : 115-129

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fluorescence lifetime assays: current advances and applications in drug discovery

By Pritz Stephan   Doering Klaus   Woelcke Julian   Hassiepen Ulrich  

Expert Opinion on Drug Discovery, Vol. 6, Iss. 6, 2011-06 ,pp. : 663-670

Informa Healthcare

Access to resources Recommend Favorite

Personalized medicine in oncology: where have we come from and where are we going?

By André Fabrice   Ciccolini Joseph   Spano Jean-Philippe   Penault-Llorca Frédérique   Mounier Nicolas   Freyer Gilles   Blay Jean-Yves   Milano Gérard  

Pharmacogenomics, Vol. 14, Iss. 8, 2013-06 ,pp. : 931-939

Future Medicine

Access to resources Recommend Favorite

Paediatric Pharmacy in Australia: Where Have We Come From and Where Do We Need To Go?

By  

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 43, Iss. 1, 2013-03 ,pp. : 45-48

John Wiley & Sons Inc

Access to resources Recommend Favorite

In Vitro Solubility Assays in Drug Discovery

By  

Current Drug Metabolism, Vol. 9, Iss. 9, 2008-11 ,pp. : 879-885

Bentham Science Publishers

Access to resources Recommend Favorite

Designing in vitro assays for drug discovery: a study with the human MAP3 kinase COT

By Jia Yong   Quinn Christopher M   Talanian Robert V  

Expert Opinion on Drug Discovery, Vol. 2, Iss. 7, 2007-07 ,pp. : 909-915

Informa Healthcare

Access to resources Recommend Favorite